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human B cell subsets and their phenotype in peripheral blood mononuclear cells (PBMC) in healthy donors and in the context of chronic viral diseases such as Human Immunodeficiency Virus 1 (HIV-1) infection. The panel encompasses a range of backbone markers for the accurate definition of common B cell subsets with a focus on memory B cells and a unique collection of phenotypic markers (chemokine receptors, cytokine receptor, B cell receptor isotypes, and proliferation marker) not combined in multicolor flow cytometry B cell phenotyping thus far. This new panel allows highly detailed phenotypic and functional investigations of B cell subsets. The panel was validated using cryopreserved PBMC from healthy and HIV-1 infected donors allowing the retrospective analysis of clinical samples (Table 1) .
BACKGROUND
Chronic viral diseases such as HIV-1 and Hepatitis C virus result in dramatic perturbations of the B cell compartment, most strikingly a shift toward mature and exhausted phenotypes and increased frequencies of immature CD10
1 transitional B cells (1) (2) (3) . As a consequence, B cell responses in HIV-1 infection are frequently impaired, resulting in delayed and, in part, insufficient humoral responses to diverse infectious agents and vaccines (4) (5) (6) (7) (8) (9) (10) . The comprehensive 18-parameter panel described herein will allow in-depth analysis of B cell dynamics with a focus on memory B cells in healthy individuals and during disease in frozen, banked PBMC samples.
B cells can be defined by expression of the canonical marker CD19. We used a dump channel including CD3, CD14, CD16, and a Live/Dead dye to achieve optimal resolution between CD19
1 and CD19 -cell types to allow definition and inclusion of CD19 dim plasmablasts into the analysis (Fig. 1A) . CD10 was included in the panel for detection of CD10 1 transitional B cells (Figs. 1A and B and Supporting Information Fig. S10 ). While transitional B cells can also be defined by the classical Bm1-Bm5 classification based on CD38 and IgD expression (11), we found that this was less reliable compared to using CD10 expression (11, 12) .
CD38 was included to define plasmablasts. Using a CD38 specific reagent labeled with the dim fluorochrome Alexa Fluor 700 (AF700) allowed to define plasmablasts readily as these cells express high levels of CD38 ( Fig. 1C and Supporting Information Fig. S11 ) (11 (13, 14) , which can be distinguished by the differential expression of the memory B cell marker CD27 (Fig. 1C) . Na€ ıve B cells do not express CD27 but express high levels of IgD, whereas IgD on MZ B cells is lower and paired with Figure 1C can be further divided in subsets based on their maturation state by expression patterns of CD21 and CD27 as described (3, 18, 29) . In HIV-1 infected patients the distribution is known to be skewed toward activated (AM) and tissue-like (TLM) memory B cells (3, 18, 29) . The analysis of cell samples from HIV-1 infection ( Figure 1D, right panel) (TLM, CD21 -CD27 -) B cells (Fig. 1D) (3, 18) . To obtain a refined dissection of phenotypic differences amongst the memory B cell subsets our staining panel monitors IgA, IgG1, and IgG3 B cell receptor isotypes (Fig. 1E) . We included in our panel IgG1 and IgG3 as these specificities were of interest in the context of the research question we addressed when developing the panel, where we were aimed to monitor HIV-1 Env IgG1 and IgG3 responses linked with the development of neutralization breadth. Depending on the research topic addressed the addition of IgM to also define IgM-only memory B cells may be of interest. For an easy adaptation of the panel to incorporate IgM or other markers we recommend markers in the FITC and PE channel, which in the present setting of our panel are occupied by IgG1 and IgG3. These markers can, however, be readily swopped to other markers (e.g., pan IgG or IgM) as needed since PE and FITC labeled reagents are among the most widely available reagents.
Chemokine receptors CCR7, CXCR3, CXCR4, and CXCR5 are measured herein to provide insight into the potential tissue destination and migratory profiles of the diverse B cell subsets, (Figs. 1F-H) . CXCR4, the chemokine receptor for CXCL12, is important for homing of B cells to bone marrow and lymphoid organs, including the spleen (19, 20) . In B cell follicles, follicular dendritic cells secrete high levels of CXCL13, which attract CXCR5-expressing B cells. CCR7 plays an important role guiding cells to the T cell areas in secondary lymph organs. CXCR3-expressing B cells are attracted to inflamed tissues by CXCL9 and CXCL10 produced at sites with ongoing immune activation.
An additional marker included in our panel is IL-21R (Fig. 1F) . IL-21, mainly secreted by follicular helper T cells in the GC, supports somatic hypermutation (SHM) and isotype switching through signaling of the IL-21R and is crucial for the development of high-affinity antibody responses (21) (22) (23) (24) (25) . Including IL-21R in the B cell panel enables analysis of the dynamics of IL-21R expression. This allows one to determine whether chronic viral infections manipulate the responsiveness of B cells to SHM and isotype class switching through regulation of IL-21R (22, 23, 26) .
Examination of the proliferation marker Ki67 identifies recently activated B cells and makes it possible to define their phenotype and dynamics during ongoing immune responses (Fig. 1H) (27) .
Combining classical lineage markers with a range of phenotypic parameters (Table 2 ) our comprehensive 18-parameter B cell panel provides the possibility for a highly detailed characterization of the B cell compartment in healthy individuals, as well as in response to infections or in autoimmune diseases.
SIMILARITY TO PUBLISHED OMIPS
This panel can be used for in-depth phenotyping of B cells in peripheral blood samples. The panel differs from the panel described by Wei et al. ] which focused on memory B cells. In contrast, the panel described here allows the analysis of most known B cell subsets and in addition includes phenotypic assessment of chemokine receptors, IL-21R, B cell receptor isotypes and the proliferation marker Ki-67.
